Skip to content
Brilliant Blue Biosciences logoBrilliant BlueBiosciences
Articles

Papers, explained in our own words

Every entry summarises what the study set out to test, what it found and why it changes how we design delivery systems. Browse research and reviews or search the collection.

586 articles

Showing 1–7 of 7 articles · Keyword: drug delivery systems Clear keyword

Assay and drug development technologies2026ReviewDrug Delivery

1. Translational Strategies in Smart Drug Delivery Systems for Controlled and Personalized Pharmacokinetics

Thalluri C, Bukke Spn, Medhi J, Vasam M, Vidiyala N, Sunkishala P, Et Al.

Advancements in drug delivery systems (DDSs) have developed pharmacotherapy by enabling precise control over drug pharmacokinetics (PKs), enhancing therapeutic efficacy, minimizing toxicity, and improving patient compliance. This review comprehensively examines emerging DDS strategies designed to optimize absorption…

Read the article
Journal of biomaterials science. Polymer edition2026ReviewNon-viral Gene DeliveryDrug Delivery

2. An insights into impact of nanocarriers bearing phytopharmaceuticals in the management of cancer

Kaushik R, Sharma V, Kumar S, Kumar Verma K, Kumar Gaur P

Cancer remains a formidable disease, with conventional treatment strategies including chemotherapy and surgery etc. Phytomolecules and their lead molecules have been employed to reduce cancer burden but have various limitations in cancer treatment. Nanocarrier-mediated delivery of phytochemicals has emerged as an…

Read the article
International journal of pharmaceutics: X2026ReviewDrug Delivery

3. Precision engineering of nanocarriers for transport across complex biological barriers

Acharya R, Komedchikova E, Choi Y, Yang J, Kim J, Son J, Et Al.

Biological barriers are essential for maintaining tissue homeostasis and protecting organs from harmful external agents; however, they also represent major obstacles to the efficient delivery of therapeutic agents. The blood-brain barrier, ocular barriers, mucosal barriers, and vascular endothelial barriers exhibit…

Read the article
Frontiers in bioengineering and biotechnology2026ReviewDrug Delivery

4. Smart nanocarriers and biomaterials for targeted drug delivery in spinal cord injury: molecular mechanisms and translational perspectives

Han W, Qi P, Li J, Min L, Li H, Yin H

Spinal cord injury (SCI) results in permanent motor, sensory, and autonomic dysfunction below the level of injury; currently, there are no effective treatments to promote neural functional recovery. Inflammatory responses, oxidative stress, apoptosis, excitotoxicity, glial scarring, and impaired axonal…

Read the article
The Journal of pharmacy and pharmacology2026ReviewDrug Delivery

5. Bioengineered multifunctional nanomedicine for cancer theranostics: integrating targeted drug delivery, molecular imaging, and precision medicine

Dubey S, Prakash S, Deshwal Rk, Dwivedi M

Cancer remains a major global health challenge despite significant advances in diagnosis and treatment. Conventional therapies, including chemotherapy, radiotherapy, and surgery, are frequently constrained by non-specific drug distribution, systemic toxicity, multidrug resistance (MDR), and limitations in early tumor…

Read the article
Cancers2026ReviewNon-viral Gene DeliveryDrug Delivery

6. Drug Delivery Systems for Breast Cancer Treatment: From Design Principles to Clinical Translation

Sescu Va, Condriuc Ips, Spridon Lg, Cadinoiu An, Miron L, Atanase Li, Et Al.

Breast cancer is the most frequently diagnosed malignancy worldwide and remains a major cause of cancer-related mortality among women. Despite advances in screening, molecular classification, and systemic therapies, treatment of advanced and metastatic disease remains challenging because of tumor heterogeneity…

Read the article
Drug development and industrial pharmacy2026ReviewNon-viral Gene DeliveryDrug Delivery

7. Harnessing the Potential of Phospholipids as Pharmaceutical Excipients: A Versatile Platform for Customized Drug Delivery Systems

Joseph At, Ravindran S

This review critically examines phospholipids as pharmaceutical excipients, focusing on physicochemical properties, self-assembly behavior, drug delivery applications, translational limitations, and future opportunities in customised therapeutics. Phospholipids have evolved from inert excipients into multifunctional…

Read the article
Articles | Brilliant Blue Biosciences